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ABSTRACT
Objective: The objective of this study was to evalua-
te the effect of bone-marrow centrifugate on the healing 
of muscle injuries in rabbits. Methods: This experimen-
tal study involved use of fifteen adult male New Zealand 
White rabbits. Each animal received a transverse lesion in 
the middle of the right tibialis anterior muscle, to which 
an absorbable collagen sponge, soaked in a centrifugate 
of bone marrow aspirate from the ipsilateral iliac bone, 
was added. The left hind limb was used as a control and 
underwent the same injury, but in this case only the ab-
sorbable collagen sponge. Thirty days later, the animals 
were sacrificed to study the muscle healing. These muscle 
areas were subjected to histological analysis with histo-
morphometry, with the aim of measuring the number of 
muscle cells per square micrometer undergoing regenera-
tion and the proportion of resultant fibrosis. Results: The 
centrifugation method used in this study resulted in an 
average concentration of nucleated cells greater than the 
number of these cells in original aspirates, without causing 
significant cell destruction. Addition of the bone marrow 
centrifugate did not result in any significant increase in 
the number of muscle cells undergoing regeneration, in 
relation to the control group. There was also no significant 
difference in the proportion of resultant fibrosis, compared 
with the control group. Conclusion: Administration of the 
bone marrow centrifugate used in this study did not favor 
healing of muscle injuries in rabbits. 
Keywords - Bone Marrow; Stem Cells; Regeneration; Ske-
letal Muscle; Animals Models; Rabbits
INTRODUCTION
Muscle injuries constitute one of the most chal-
lenging problems of sports traumatology, since al-
though common, their treatment is still controver-
sial, and often inefficient(1). Long periods of leave of 
absence are habitually necessary for athletes to fully 
resume their activities and sequelae can be part of the 
end result(2). 
The muscle tissue healing process usually starts 
promptly as soon as a trauma occurs; however, it can 
evolve slowly and irregularly, hindered by an exces-
sive formation of connective scar tissue (fibrosis)(3). 
This scar tissue in excess inhibits the complete rege-
neration of the preexisting muscle structure, and, as 
it is more fragile and anomalous, contributes towards 
the local recurrence of the lesion, preventing the com-
plete recovery of muscle function(4). 
The treatment employed most often in muscle in-
juries is conservative, involving measures such as 
rest, immobilization of the affected limb for a variable 
time, local application of ice and physiotherapeutic 
monitoring. In some cases, depending on the severi-
ty of the lesion, its surgical repair may be indicated. 
Although these treatments frequently lead to good 
clinical results, they appear to have a limited effect 
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on functional recovery and the risk of recurrence(2).
The limitations described gave rise to surveys 
investigating biological measures capable of sti-
mulating the muscle regeneration process and of 
preventing fibrosis formation(5). This resulted in a 
better identification of the cellular and molecular 
pathways involved in muscle regeneration and in 
a more complete understanding of the activity of 
satellite cells and pluripotent cells, capable of myo-
genic differentiation during muscle healing(6,7). This 
better understanding of the muscle repair process 
made room for favorable prospects in the appear-
ance of new therapies(8). 
Tissue repair, replacement and regeneration tech-
niques, employing tissue engineering knowledge 
have recently achieved promising results, which in-
clude the capturing and transplantation of precur-
sor cells and the use of bioactive matrices, peptide 
hormones and growth factors(9). 
Among these new techniques, two lines of re-
search have been studied extensively: 1) the local 
application of platelet-rich plasma, due to its sup-
posed healing properties, attributed to the ability to 
recruit, proliferate and differentiate cells involved 
in tissue repair; and 2) therapies based on the direct 
local addition of embryonic stem cell cultures, in 
the hope that the latter will differentiate in the cells 
of the target tissue.
Although therapies based on the local addition of 
embryonic stem cell cultures produced in vitro have 
demonstrated the ability to differentiate into muscle 
cells (myocytes)(10,11), the culturing and the trans-
plantation of undifferentiated bone marrow cells are 
complex, costly procedures with technology restric-
ted to large research centers(12). Consequently, the 
local application of bone marrow aspirates contai-
ning adult stem cells has been researched clinically 
and experimentally(13). The latter have limited tissue 
differentiation potential in comparison to embryo-
nic stem cells, yet they are able to produce bone, 
cartilaginous and muscle cells(14). Since the local 
addition of myocytes is related to an increase of 
muscle regeneration at the lesion site, the local ap-
plication of a sufficient number of their precursor 
cells constitutes a promising approach in the attempt 
to improve muscle healing(15,16).
The aim of this study was to evaluate the positive 
effect of the addition of bone-marrow centrifugate in 
the healing of muscle injuries in rabbits.
METHODS
This experimental study was evaluated and ap-
proved, on March 13, 2007, by the Animal Research 
Ethics Committee of Universidade Estadual de Lon-
drina. 
The study subjects were 15 adult male New Zea-
land White (Orytolagus cuniculus) rabbits with mean 
weight of 3 kg and approximate age of four months, 
from the Experimental Farm of Iguatemi, of Univer-
sidade Estadual de Maringá, and bred in the Vivarium 
of the Health Sciences Center, of Universidade Estad-
ual de Londrina. As there is no consensus in literature 
regarding the appropriate method for calculating the 
size of the ideal sample for the study in question, we 
opted to use a number of animals similar to that used 
in the reference studies. Moreover, the current ethical 
guidelines for animal research recommend the use 
of the lowest possible number of animals, as long as 
they provide significant statistical results. The ani-
mals were evaluated previously by a veterinarian and 
were accommodated in individual metal cages, with 
12 continuous hours of daily light, and with room 
temperature, humidity and noise kept stable. Their 
diet consisted of water ad libitum and appropriate 
balanced and pelleted industrial feed. 
Preparation of the bone marrow centrifugate
The anesthetic procedure was based on the anes-
thesia protocol advocated by the Canadian Council on 
Animal Care, in the Guide to the Care and Uses of Ex-
perimental Animals(17). One mg/kg of atropine sulfate 
was applied in each animal by intramuscular route 
as a preanesthetic medication. The anesthesia started 
with the intramuscular application, in the proximal 
region of the pelvic limb, of a solution containing 
40 mg/kg of 10% ketamine chlorhydrate, associated 
with 5 mg/kg of xylazine chlorhydrate. Soon after the 
anesthesia induction, the animals were identified with 
numbers ranging from 1 to 15, tattooed in the left ear. 
The fractionated administration of 1 mg/kg xylazine 
chlorhydrate was performed when it was necessary to 
prolong the anesthesia. 
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The skin of the right iliac crest region was trichoto-
mized, and after appropriate asepsis and antisepsis, 
the surgeon performed the puncture of the bone mar-
row from the posterior iliac crest, using a 16G needle 
with trocar. The medullary cavity was reached with 
delicate rotation movements. After this, the trocar was 
removed, connecting to the needle a 10 ml dispo-
sable plastic syringe, the inside of which had been 
previously soaked in a heparin solution at 1:1.000. 
Approximately 5 ml of bone marrow were aspirated 
with firm traction of the syringe piston. 
The material was processed in a laminar flow 
chamber under sterile conditions. To disperse the 
cellular aggregates, the 5 ml sample from the plastic 
syringe was transferred to a sterile graduated tube, 
initially through a 19 gauge needle, then using a 22 
gauge needle. The material was centrifuged at 400G 
and at 20°C, for 10 minutes. After centrifugation, the 
aspirate split into three distinct levels: an upper layer 
containing the blood plasma, an intermediate layer 
known as the buffy-coat, where we can find the nucle-
ated cells (due to their greater density), which include 
hematopoietic precursor cells and marrow stromal 
cells, the site where it is possible to find the mesen-
chymal and progenitor cells (bone, cartilaginous and 
muscle cell precursors). Finally, the last layer is com-
posed of the red cells sedimented at the bottom of the 
tube. The buffy-coat material was then homogenized, 
and a sample of 50 microliters was separated to count 
the cells and to carry out a cell viability test, to avoid 
the administration of dead cells that could result from 
the centrifugation process. 
Surgical technique
The anesthetized animal was positioned in dorsal 
decubitus on the operating table, performing tricho-
tomy of the anterior surfaces of the right and left 
legs, and appropriate asepsis and antisepsis. 
A longitudinal, anteromedial access route was 
made in the middle third of the hind limb, approxi-
mately 3 cm in length. This was followed by dis-
section by planes, approaching skin, subcutaneous 
tissue and fascia, which were pulled aside, exposing 
the body of the tibialis anterior muscle. Using a no. 
15 scalpel blade, a crosswise incision was made in 
the body of the tibialis anterior muscle, covering 
75% of its width, 50% of its thickness and approxi-
mately 60% of its length, starting from its proximal 
origin, according to the model of Menetrey et al(18). 
This is done to avoid the total crosswise section of 
the muscular venter, enabling more uniform healing 
between the muscle portions separated by the incision 
and sparing the motor nerve at its point of penetration 
in the muscle(6).
After this, the surgeon placed proximal and distal 
repair stitches at a distance of 5 mm from the edges of 
the muscle injury, using 4.0 mononylon suture thread, 
according to the procedure recommended by Mar-
low et al(19). A sample of absorbable gelatin sponge 
(Gelfoam®) measuring 1.0 x 0.5 cm was soaked in 
the bone marrow centrifugate and placed over the 
lesion (Figure 1).
The surgical wound was sutured by planes using 
4.0 mononylon suture thread and occluded with a 
sterile impermeable dressing. The same procedure 
was carried out in the left tibialis anterior muscle; 
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yet only the absorbable gelatin sponge was applied 
at the site.
At the end of surgery, the animal was isolated from 
the other animals, placed in an appropriate box and 
heated. An intramuscular dose of antibacterial and 
anti-inflammatory drug containing penicillin G ben-
zathine, penicillin G procaine, dihydrostreptomycin 
sulfate and piroxicam was administered. After total 
recovery from anesthesia, the rabbit was returned to 
its cage, receiving water and feed ad libitum. Full 
weight-bearing on the operated limbs was authorized 
and allowed immediately, without any type of restric-
tion or immobilization. According to Järvinen et al(1), 
early mobilization induces faster and more intense 
capillary growth into the injured area, better regenera-
tion and more parallel muscle fiber orientation, while 
inactivity is associated with significant atrophy of the 
muscle fibers and excessive fibrosis deposition. 
Thirty days after the surgery date, the animals were 
sacrificed. The right and left tibialis anterior muscles 
of each animal were carefully dissected from their 
proximal to their distal insertion and removed. The 
proximal and distal surgical repair stitches were lo-
cated, 5 mm from the lesion site, and the muscle was 
sectioned between these stitches, according to the 
experimental model described by Menetrey et al(18).
After this, the proximal and distal halves of the mus-
cles were placed in appropriate containers, fixed in a 
10% formalin solution, and identified with the rabbit’s 
number and corresponding hind limb (right or left).
The muscle tissue samples were then dehydrated 
and soaked in paraffin for the histological study, po-
sitioned in such a way that the location of the surface 
of the middle line would allow cross sections from the 
middle point of the injury. Histological sections with 
a thickness of 4µm were obtained from the paraffin 
blocks, and followed the histological routine for stai-
ning with hematoxylin-eosin, for histopathological 
and histomorphometric evaluation.
The evaluation of results was performed by the 
quantitative histological measurement (number of 
muscle cells per µm2 and proportion of fibrosis) of 
healing of the muscle injury, comparing the right ti-
bialis anterior muscle with the left from the surface of 
the middle line of their segments, in the intermediate 
region of the muscle injury, which is the ideal region 
for quantification of muscle regeneration, as it occurs 
regardless of vascular supply and in an environment 
not influenced by fibrous repair, reflecting only the 
myogenic potential. 
The findings were then documented in scanned 
images captured with the assistance of the Kontron 
Electronic 300 (Zeiss®) image analysis system, for the 
quantitative evaluation. This semi-automated routine 
was carried out in each field of the slide under analy-
sis, with 10 fields per slide. The results obtained in 
each field, corresponding to the analyzed area (num-
ber of muscle cells per µm2 and proportion of fibro-
sis), were filed in a Microsoft Excel® spreadsheet for 
subsequent statistical analysis. 
The statistical analysis was performed in the De-
partment of Statistics of the Center of Exact Sciences 
of Universidade Estadual de Londrina.
The mean, the standard deviation, the median and 
the interquartile amplitude of the continuous quantita-
tive variables were all measured.
Statistical tables and column charts (mean ± stan-
dard deviation) presented the descriptive statistics of 
the variables: number of muscle cells/µm2 and propor-
tion of fibrosis. 
Wilcoxon’s test was used for inference on the dif-
ference between the observations of the paired and 
nonparametric samples. 
The significance level adopted wasĮ 
RESULTS
Table 1 contains the results of the cell count and 
of the cell viability test, carried out after the bone 
marrow aspirate centrifugation. 
Table 2 and Figure 2 demonstrate the number of 
muscle cells per square micrometer formed at the site 
of the muscle injury, treated with bone marrow cen-
trifugate, in comparison to the control group.
Table 3 and Figure 3 demonstrate the percentage of 
fibrosis formed at the site of the muscle injury, treated 
with bone marrow centrifugate, in comparison to the 
control group.
DISCUSSION
Muscle injuries are extremely common, constitu-
ting around 35-55% of all sports-related injuries. The 
associated morbidity is significant since these injuries 
can lead to painful muscle contractures and atrophies, 
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Table 1 – Descriptive statistics of the nucleated cell count in each sample of bone marrow aspirate and determination of their cell viability.
Rabbit
Puncture 
volume 
(ml)
Mean count 
(107 cells/
ml)
Nucleated cell
Viable Non-viable
Cell viability 
(%)
VW QG M VW QG M M 
1    100  2 4  #  
2      1 1 1 # 1 
    44  1 1 1 # 1 
4   40 47 44 1 2 2 # 2 
     76 1  2 # 2 
6    62 64    #  
7       1 2 # 2 
   66   6  7 # 7 
      2 4  #  
10      4   #  
11      2 4  #  
12    71  6  6 # 6 
   47 40 44    #  
14   72 77  2 6 4 # 4 
    42  2 4  # 
1st – First count – 2nd – Second count – M – Mean count
Table 2 – 'HVFULSWLYH VWDWLVWLFV RI WKH QXPEHU RI PXVFOH FHOOVIRUPHGDWWKHVLWHRIWKHPXVFOHLQMXU\FRPSDULQJWKHVLGHZKHUHWKHERQHPDUURZFHQWULIXJDWHZDVDSSOLHGZLWKWKHFRQWUROVLGH
Rabbit
Number of muscle cells/µm
2
Bone marrow 
centrifugate (BMC)
Control (C)
1  
2    
4    
6  
7      
10  
11  
12    
14    0HDQVWDQGDUGGHYLDWLRQ  'LIIHUHQFH%0&&   0HGLDQLQWHUTXDUWLOHDPSOLWXGH  'LIIHUHQFH%0&&   :LOFR[RQ 6  S 
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require long periods of recovery, increase the risk of 
recurrence and, in some cases, make it difficult for 
athletes to return to their pre-injury activity level. 
In recent years, the development of cell and tissue 
engineering therapies has stimulated research em-
ploying these techniques in the treatment of muscle 
injuries. The purpose of these therapies is to stimulate 
an increase in the formation of muscle cells in the 
affected region, and, at the same time, to reduce the 
formation of excess connective scar tissue (fibrosis). 
The latter is directly related to the rate of recurrent 
injuries and has been shown capable of preventing 
athletes from returning to their pre-injury state, partly 
as it prevents the formation of new myofibrils, con-
tributing towards the decline of muscle contractility 
and of range of motion(20). The pain resulting from 
the formation of fibrosis is also a limiting factor for 
total functional recovery during physiotherapy and in 
the long-term.
Although studies evidence the ability of embryo-
nic progenitor cell (embryonic stem cell) cultures to 
form bone, cartilaginous and muscle tissues, this te-
chnology is expensive and complex, and, therefore, 
still far from the daily clinical practice. Because of 
this, the initiative of our using in our survey aspirates 
from bone marrow, which demonstrably contains, in 
its stroma, adult mesenchymal tissue precursor cells. 
These cells also present the potential, although more 
limited than the embryonic precursory cells, to diffe-
rentiate into muscle cells. 
We use the muscle injury model described by Me-
netrey et al(18), which impedes the total separation of 
the muscle fibers, favoring the study of healing. On 
the lesion site, we apply absorbable collagen foam, 
soaked in the bone marrow centrifugate, to prevent 
the dispersion of the cells and to allow their more 
prolonged contact with the lesion, since the foam re-
mains at the site for approximately fifteen days befo-
re being absorbed completely. The samples of bone 
marrow aspirate were centrifuged with the objective 
of separating the nucleated cells, of which both hema-
topoietic precursor cells and stromal cells form part. 
After the centrifugation process is complete, these 
cells are concentrated in the intermediate layer of the 
tubes (buffy-coat).
Although the model used does not faithfully repro-
duce the muscle injuries most frequently encountered 
Table 3 – Comparative descriptive statistics of the percentage of 
fibrosis formed at the muscle injury sites.
Rabbit
Proportion of fibrosis
Bone marrow 
centrifugate (BMC) Control (C)
1 0.601304503 0.469212643
2 0.525683356 0.642372385
3 0.361749355 0.445195018
4 0.666412294 0.377530994
5 0.676205576 0.593659394
6 0.343374895 0.699801392
7 0.555734885 0.500963831
8 0.500546007 0.583348253
9 0.387811732 0.379854791
10 0.567422834 0.491287125
11 0.646452016 0.37336342
12 0.663838047 0.543644596
13 0.630006334 0.513283371
14 0.302357471 0.672787984
15 0.59545864 0.448178945
Mean ± standard 
deviation 0.534957 ± 0.12778 0.515632 ± 0.10568
Difference (BMC-C) 0.019325 ± 0.19402  
Median (interquartile 
amplitude) 0.567423 (0.25864) 0.500964 (0.14846)
Difference (BMC-C) 0.076136 (0.21554)  
Wilcoxon S = 13 p = 0.4887
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in the clinical practice, which are those caused by 
contusion or laceration mechanism, we opted for 
the model proposed by the cited authors as it al-
lows a better standardization of the injury in each 
animal. According to these authors, this model is 
easy to execute and eliminates variables such as 
extension, depth and intensity of the force applied 
when attempting to cause the injury by contusion 
or laceration, allowing a better characterization of 
the muscle healing. 
Another conflicting factor in our study was the 
option to sacrifice the animals with a single time 
interval of four weeks. Ideally, we should evaluate 
the healing in several periods, which would allow a 
more uniform and linear follow-up. However, this 
would require a much larger sample group of ani-
mals, which has been discouraged by animal protec-
tion societies and animal welfare boards. Nowadays 
they advocate the use of the lowest possible quantity 
of animals, and uphold that people should preferably 
work at tissue level (histology). Moreover, there is 
no standardization, in literature, of the calculation 
of the most appropriate number of animals for this 
type of study. 
In spite of all these precautions, our results de-
monstrated that there was no significant difference in 
the number of muscle cells formed at the site of the 
muscle lesions where the bone marrow centrifugate 
was applied, in comparison with the control side. 
Neither was there any difference in the percentage of 
fibrosis formed, which allows us to conclude that the 
bone marrow concentrate was not able to improve 
the quality of the muscle scar. 
Although literature frequently refers to mesen-
chymal progenitor cells of the bone marrow as a 
homogeneous population, these cells are actually 
very heterogeneous, differing greatly in their ability 
to differentiate into adult muscle cells. Therefore, 
even when the same technique is employed for their 
obtainment, bone marrow aspirates can be very dif-
ferent in relation to the quantity of truly precursor 
cells present in each collected sample. This may be 
one of the causes of failure in our study. According 
to Matziolis et al(21), the inflammatory process trig-
gered by a muscle injury can lead to the death of the 
myogenic precursor cells implanted immediately, 
which may result in cell survival below 10% on the 
fifth day after the trauma. This is apparently caused 
by the cellular and humoral factors that form part 
of the physiological inflammation processes during 
the first days after the injury. Moreover, the damage 
to microvascularization results in poor regenerative 
response in this phase. Together, these factors create 
a hostile environment that hinders the survival, the 
proliferation and the differentiation of transplanted 
cells, contributing to justify the negative results 
found in our study.
Although tissue regeneration mediated by em-
bryonic stem cells in vitro has promising therapeu-
tic potential, Musarò et al(10) believe that the diffe-
rentiation in the skeletal muscle of adult stem cells 
originating from the bone marrow has hardly any 
clinical import. 
In this study, the greater proportion of fibrosis in 
the treatment group, although not significant, came 
as a surprise, demonstrating that the excessive for-
mation of connective scar tissue, in the opinion of 
other authors, is a problem yet to be resolved. 
The results obtained in this study demonstrate 
that the bone marrow centrifugate was not able to 
induce a better quality of muscle healing, increasing 
the number of muscle fibers and reducing fibrosis 
formation. 
One alterative that has been the focus of recent 
surveys seeking to repair and/or to regenerate the 
muscle tissue is the use of platelet concentrate, also 
known as platelet-rich plasma (PRP)(22). 
The platelets are the first cells to reach the site 
of the injury and are very active in the initial in-
flammatory phase of tissue repair. They act in tissue 
homeostasis, by means of adherence, aggregation, 
formation of clots and release of substances (growth 
factors) that promote tissue repair and that influence 
local neovascularization(23). 
Platelets release growth factors through degranu-
lation, and the interest in their local application at 
lesion sites is due precisely to the possibility of en-
hancing tissue healing potential through the direct 
administration of these factors. These factors are 
concentrated by means of techniques of centrifuga-
tion of autologous blood from the actual patient, pro-
ducing a platelet-rich substance that can be applied 
in liquid or gelatinous form on the injured tissue(23). 
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In spite of its considerable appeal, recent studies 
have demonstrated that there is still a great deal 
of controversy regarding the true efficacy of PRP, 
mainly due to the non-standardization of variables 
such as quantity to be applied, concentration, time 
interval etc. Most surveys appear to demonstrate a fa-
vorable effect in the treatment of chronic tendinosis, but 
conflicting results in bone and muscle application(24). 
Further studies should be conducted, perhaps using 
homogeneous populations of mesenchymal progenitor 
cells, in an attempt to regenerate the muscle fibers, 
resulting in more adequate muscle healing and in the 
complete recovery of pre-injury muscle function. 
CONCLUSION 
The administration of the bone marrow centrifu-
gate used in this study did not favor the healing of 
muscle injuries in rabbits.
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